IBEC Group Leader Silvia Muro, elected to join the American medical and biological engineering elite

The College of Fellows is comprised of the top two percent of medical and biological engineers in the USA.
Silvia Muro, Group Leader at Institute for Bioengineering of Catalonia (IBEC) and ICREA Research Professor, has been elected to join the American Institute for Medical and Biological Engineering (AIMBE). Dr. Muro was nominated, reviewed, and elected by peers and members of the College of Fellows for generating knowledge to advance drug delivery by bridging the gap between molecular-cellular biology and nanotechnology. The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs comprise the College of Fellows. AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Nobel Prize, the Presidential Medal of Science and the Presidential Medal of Technology and Innovation and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences. A formal induction ceremony will be held during AIMBE’s 2021 Annual Event on March 26. Dr. Muro will be inducted along with 174 colleagues who make up the AIMBE Fellow Class of 2021.

I am honored to become an AIMBE member. This is a motivating recognition to our work on drug delivery and nanomedicine within the bioengineering field.

Research Professor Silvia Muro

About the American Institute for Medical and Biological Engineering (AIMBE)

AIMBE’s mission is to recognize excellence in, and advocate for, the fields of medical and biological engineering in order to advance society. Since 1991, AIMBE’s College of Fellows has led the way for technological growth and advancement in the fields of medical and biological engineering. AIMBE Fellows have helped revolutionize medicine and related fields to enhance and extend the lives of people all over the world. They have successfully advocated for public policies that have enabled researchers and business-makers to further the interests of engineers, teachers, scientists, clinical practitioners, and ultimately, patients.

For more information about the AIMBE Annual Event, please visit

About Silvia Muro

Dr. Silvia Muro obtained her PhD in Sciences from Universidad Autónoma de Madrid and then moved to University of Pennsylvania as a Postdoctoral Associate first and then a Research Assistant Professor in Pharmacology. In 2008 she joined the Institute for Bioscience and Biotechnology Research and the Bioengineering Department at the University of Maryland, where she was a tenured Associate Professor since 2012. Since November 2017, she is an ICREA Professor in the Institute for Bioengineering of Catalonia. Dr. Muro has published 95 articles and chapters and has received awards from the Controlled Release Society, the American Society for Nanomedicine, the UMD Outstanding Life Sciences Invention and Junior Faculty Outstanding Engineering Research award, was an elected member of the NIH NANO Study Section, and serves on the editorial board of several drug delivery journals.